Role of the laboratory in ensuring global access to ARV treatment for HIV-infected children: consensus statement on the performance of laboratory assays for early infant diagnosis.
Role of the laboratory in ensuring global access to ARV treatment for HIV-infected children: consensus statement on the performance of laboratory assays for early infant diagnosis.
复制标题
实验室在确保全球访问HIV感染儿童的ARV治疗方面的作用:关于早期婴儿诊断实验室测定的共识声明。
DOI:
10.2174/1874613600802010017
复制
发表时间:
2008
期刊:
影响因子:
--
通讯作者:
Nkengasong JN
中科院分区:
文献类型:
--
作者:
Stevens W;Sherman G;Downing R;Parsons LM;Ou CY;Crowley S;Gershy-Damet GM;Fransen K;Bulterys M;Lu L;Homsy J;Finkbeiner T;Nkengasong JN
A two day meeting hosted by the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) was held in May 2006 in Entebbe, Uganda to review the laboratory performance of virologic molecular methods, particularly the Roche Amplicor DNA PCR version 1.5 assay, in the diagnosis of HIV-1 infection in infants. The meeting was attended by approximately 60 participants from 17 countries. Data on the performance and limitations of the HIV-1 DNA PCR assay from 9 African countries with high-burdens of HIV/AIDS were shared with respect to different settings and HIV- subtypes. A consensus statement on the use of the assay for early infant diagnosis was developed and areas of needed operational research were identified. In addition, consensus was reached on the usefulness of dried blood spot (DBS) specimens in childhood as a means for ensuring greater accessibility to serologic and virologic HIV testing for the paediatric population.